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Abstract
Background: Khat is an amphetamine like psychostimulant chewed by over 10 million people globally. Khat use is
thought to increase the risk of psychosis among its chewers. The evidence around this however remains
inconclusive stemming from the scanty number of studies in this area and small study sample sizes. We undertook
a large household survey to determine the association between psychotic symptoms and khat chewing in a rural
khat growing and chewing population in Kenya.
Methods: For this cross-sectional household survey, we randomly selected 831 participants aged 10 years and above
residing in the Eastern region of Kenya. We used the psychosis screening questionnaire (PSQ) to collect information on
psychotic symptoms and a researcher designed sociodemographic and clinical questionnaire to collect information on
its risk factors. We used descriptive analysis to describe the burden of khat chewing and other substance use as well as
rates and types of psychotic symptoms. Using a univariate and multivariate analyses with 95% confidence interval, we
estimated the association between khat chewing and specific psychotic symptoms.
Results: The prevalence of current khat chewing in the region was at 36.8% (n = 306) with a male gender
predominance (54.8%). At least one psychotic symptom was reported by 16.8% (n = 168) of the study population.
Interestingly, psychotic symptoms in general were significantly prevalent in women (19.5%) compared to men (13.6%)
(p = 0.023). Khat chewing was significantly associated with reported strange experiences (p = 0.024) and hallucinations
(p = 0.0017), the two predominantly reported psychotic symptoms. In multivariate analysis controlling for age, gender,
alcohol use and cigarette smoking, there was a positive association of strange experiences (OR, 2.45; 95%CI, 1.13–5.34)
and hallucination (OR, 2.08; 95% C.I, 1.06–4.08) with khat chewing. Of note was the high concurrent polysubstance use
among khat chewers specifically alcohol use (78.4%) and cigarette smoking (64.5%).
Conclusions: Psychotic symptoms were significantly elevated in khat users in this population. Future prospective
studies examining dose effect and age of first use may establish causality.
Keywords: Khat, Psychotic symptoms, Sub Saharan Africa, Kenya, And household survey
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Background
Catha edulis, commonly known as khat, is a psychostimulant plant used by over 10 million people daily,
mainly in eastern Africa and the Middle East [1]. Historically, khat was recognized as a ceremonial plant in
Kenya, chewed primarily by older men during special social gatherings [2]. Recently however, the pattern of khat
consumption has been slowly changing with not only a
rise in use among women and the youth but also an increase in quantity of khat chewed [3, 4]. In addition to
its longstanding traditional value, the sale of khat is an
important contributor to Kenya’s economy. Khat is currently Kenya’s highest valued horticultural export accounting for about 60% of the total value of such
exports [5]. It is mainly cultivated in the Eastern part of
Kenya and its use remains legal in the country.
Khat is primarily ingested by chewing. The leaves and
stalks of the khat plant are slowly chewed to release its
juice which is then ingested with saliva. The residual
pulp is subsequently pushed to the side of the cheek and
the mouth continuously filled with fresh leaves. The accumulated ball of residue is eventually spat out at the
end of the chewing session [6]. In addition to its euphoric acute effect, khat users also commonly report increased levels of alertness, decreased hunger and fatigue
and a general sense of wellbeing during chewing [6–8].
The euphoric effect is felt within 1 h of chewing khat.
Cathinone which is the main alkaloid constituent of khat
reaches peak plasma levels 1.5–3.5 h after the onset of
chewing [9, 10]. Its average elimination half-life is four
and half hours [11]. The acute effects of euphoria and
alertness are later proceeded by excessive feelings of
anxiety and irritability, poor concentration and insomnia
following chewing [12]. The tolerance level of khat is
low and withdrawal symptoms linked to khat use include
nightmares, tremors, depression, sedation and hypotension
[13, 14]. Chronic khat use has additionally been linked to
cardiovascular, digestive, genitourinary, endocrine and oral
dental health problems [15–19].
On average 100 g of fresh khat leaves contain 36mgs
of cathinone, 120 mg cathine and 8 mg norephedrine
[20]. Khat is chewed for its psychoactive effect is thought
to come from two phenylalkylamines; cathinone and
cathine, which are structurally related to amphetamine
[21]. Despite notable progress having been made in identifying the pharmacological basis of Khat there is divided
opinions on the potency and subsequent neurobehavioral effects. Khat’s effect on the central nervous system
is thought to act like amphetamine by increasing the activity of the dopaminergic and noradrenergic transmission. [22]. Previous studies have shown associations
between heavy khat use with psychosis and mania [23].
In addition, some studies have pointed towards khat
exacerbating or triggering primary psychotic disorders
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such as schizophrenia [24, 25]. Khat induced psychosis
has been described as transient in nature and characterized majorly by symptoms of paranoia and mania [26–28].
However, this research is non-conclusive and primarily
based on case reports [29]. Another limitation to previous
khat research is the number of neurobehavioral studies focused on highly traumatized migrant populations making
findings inconclusive as to whether the trauma or the khat
triggered the psychosis [30]. A deeper understanding of
the epidemiology of khat associated psychosis is warranted
to contribute to the evidence base necessary in developing
policies around this plant. In addition, previous local community based studies have shown relatively high rates of
participants endorsing at least one psychotic symptom
(13.9%) [31], being able to tease out the burden of psychotic symptoms attributable to khat use as compared to
other risk factors is key to understanding khat use pathophysiology. Khat remains a controversial plant with differing opinions on its benefits and negative impact on
human health [32], hence as part of the Kenyan government’s efforts to understand the burden of khat use and
its effects on human health we were tasked to conduct a
large, population based study in a rural non migrant
population of mainly khat growers. We report here findings on the prevalence of khat use and its association with
psychotic symptoms in the survey population.

Methods
Study design

We used a cross sectional study design to collect data
from randomly selected households.
Study population and setting

We conducted this study in Meru and Embu County situated in the Eastern Part of Kenya. The two counties border
each other and together occupy close to 10,000 km2. These
are the largest khat growing regions in Kenya and only second to Ethiopia in Africa.
The population of Embu County is estimated at
543,221 while Meru County population currently stands
at 1,400,000. The two communities are agrarian with a
focus on cash crop cultivation this primarily being khat.
The khat variant grown in Embu is referred to as
Muguka while the Meru variant is known as Miraa. The
two variants are physically different with the shoots for
Muguka and the leaves for miraa being chewed.
In Embu County, we identified two sub-counties (Mbeere
North & Mbeere South) as having high production of
Muguka, while in Meru, we selected four sub-counties
(Igembe North, Igembe Central, Igembe South and Tigania
East) for their high production of Miraa.
Data collection was carried out between the months of
September 2015 to December 2015.
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Participant recruitment
Sampling of clusters

Sub-areas (villages) which are the smallest administrative
units were the Primary Sampling Unit (PSU) or cluster
in this survey. Using the local administration, we listed
all sub-areas growing khat in the identified sub-counties.
We then allocated the number of clusters required for
each county (Meru and Embu) using income generated
annually as a proxy measure and applying square root
allocation method. For sub-counties, we determined the
number of clusters required using the square root allocation method based on number of sub-areas in the
sub-county growing khat.
In each of the Sub-counties, we used a two-stage cluster
sampling methodology where the first stage involved selection of required clusters for adults and children using
systematic random sampling. In the second stage we used
systematic random sampling to uniformly select 10 households from a listing of households in each cluster.
From identified adult clusters, we selected the household head and the lead spouse. From identified child
clusters, among the children aged 10–17 years in each
selected household, we randomly selected one child by
balloting if there were more than one eligible child. In
the occasion a household member was found to be unavailable during the first visit, at least two follow up
visits on two separate occasions were made to maximize
on response. Whenever there was complete failure to
get the selected household member, it was captured as a
non-response.
Sample size

Using the Fischer et al. formula and a desired precision
of 5% for the indicator with 95% confidence, we required
a minimum sample size of 385. Applying a design effect
of 2 due to cluster sampling and a non-response rate of
20% we determined a sample size rounded off to 1000.
Ethics and consent

We were granted scientific approvals; SSC number 2888
from the KEMRI Scientific Review Committee (SSC)
and the Scientific and Ethical Review Unit (SERU). We
then obtained permission to access the study sites from
the relevant authorities.
At the household level we sought informed consent
from all the adult participants prior to the interview. For
participants aged less than 18 years, informed consent
was obtained from either their parents or guardians
followed by assent by the participant. We informed participants that participation in the study was voluntary
and information collected during the study was solely
for study purpose. Participants signed written informed
consent after detailed explanation of the study purpose.
All consents and study documents were in both English
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and Kiswahili translations. We asked recruited participants to pick the language they preferred for the interview. Trained research assistants conducted interviews
in secluded areas to maintain privacy of participants. For
participants who required medical attention, we referred
them for appropriate medical care.

Variables

All study questionnaires were forward translated into
the local language (Kiswahili) and then back translated
into English. Pretesting and piloting of the study tools
was undertaken in a different locality from selected clusters for face and content validity. This ensured the content was understandable to the study population (adults
and children). Piloting procedure involved administration of the tools by the study clinicians/nurses followed
by interviews with participants about their opinions,
concerns and challenges about questions asked. Data
was collected using a structured face to face interview
format using either English or Kiswahili translations depending on the participants’ preference.
We used a researcher designed questionnaire to collect
data on socio-demographic characteristics of participants
as well as specific khat use behaviour. A separate simplified questionnaire was used for children to collect sociodemographic and khat use behaviour.
We used Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) to collect information on
other substance use [33].
We then assessed the presence of five types of psychotic symptoms (mania/hypomania, thought control,
paranoia, strange experience, and hallucinations) occurring in the past year using the Psychosis Screening
Questionnaire (PSQ) [34] . In some instances, to determine the severity of the symptoms we used one
follow-up questions after the main probe question for
each type of psychotic symptom.
The questions and response options required for
the endorsement of each psychotic symptom were as
follows:
1. Mania/hypomania: over the past year, have there
been times when you felt very happy indeed
without a break for days on end? (yes)
1a. Was there an obvious reason for this? (no)
2. Thought control: over the past year, have you ever
felt that your thoughts were directly interfered with
or controlled by some outside force or person? (yes)
2a. Did it come about in a way that many people would
find hard to believe, for instance, through
telepathy? (yes)
3. Paranoia: over the past year, have there been times
when you felt that people were againstyou? (yes)
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3a. Have there been times when you felt that people
were deliberately acting to harm you or your
interests? (yes)
4. Strange experience: over the past year, have there
been times when you felt that something strange
was going on? (yes)
4a. Was it so strange that other people would find it
very hard to believe? (yes)
5. Hallucination: over the past year, have there been
times when you heard or saw things that other
people could not? (yes)
We diagnosed probable psychosis when at least one of
the five experiences was selected.
Statistical analysis

We carried out data analysis using IBM SPSS version 21.0
statistical software and R software. Analysis included descriptive statistics (means, standard deviations & medians

for continuous variables, proportions and frequency distributions for categorical variables). We confirmed distribution characteristics using Kolmogorov-Sminorf test and
Exploratory Data Analysis (EDA) for all the continuous
data. Student T-test (for normally distributed data) and
Mann-Whitney U test (for skewed data) tested for differences in continuous variables between categories of
dependent variables. For categorical variables Chi-square
and where applicable, we used Fisher’s exact probability
tests. A p-value of < 0.05 was considered statistically significant. To determine association of psychotic symptoms
and khat chewing while controlling for effect of other variables we carried out binary logistic regression analysis.

Results
After sampling 650 households from 65 clusters (26 in
Embu and 39 in Meru) we enrolled a total of 843 participants out of an expected 1000 (313 from Embu and 530
from Meru) resulting in a non-response rate of 16%. Of

Table 1 Distribution of socio-demographic characteristics & substance use by sex
Parameter

Total

Male
Age group in years
10–17

P-value

Sex, %
Female

(N = 829)

(N = 395)

(N = 434)

33.8

31.6

35.7

18–35

28.3

22.0

34.1

36–50

23.6

26.3

21.2

14.2

20.0

9.0

(N = 549)

(N = 271)

(N = 278)

> 50
Education (Adults only)
Up to primary

84.7

80.8

88.5

Secondary

12.2

16.2

8.3

Tertiary

3.1

3.0

3.2

(N = 540)

(N = 265)

(N = 275)

Occupation (Adults only)
Formal & Self employed

13.7

17.7

9.8

Farmer

79.4

75.1

83.6

Casual, domestic & other

6.9

7.2

6.5

(N = 460)

(N = 256)

(N = 204)

< 5000

35.0

23.0

50.0

5000- < 50000

59.8

69.1

48.0

5.2

7.8

2.0

(N = 831)

(N = 396)

(N = 435)

Income (Adults only)

50000 & over
Khat use
Chewers

36.8

54.8

20.5

Non chewers

63.2

45.2

79.5

(N = 829)

(N = 395)

(N = 434)

13.4

26.3

1.6

Tobacco use (Daily or almost daily)
Yes
No

86.6

73,7

98.4

(N = 829)

(N = 395)

(N = 434)

Yes

3.7

6.3

1.4

No

96.3

93.7

98.6

Alcohol use (Daily or almost daily)

< 0.001

0.017

0.024

< 0.001

< 0.001

< 0.001

< 0.001
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these 831 completed the PSQ questionnaire with adults
making 66.3% (n = 551) of the participants.
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Table 2 Distribution of socio-demographic characteristics,
alcohol and tobacco use by Khat chewing
Parameter

Distribution of socio-demographic characteristics &
substance use by sex

The median age of participants was 30 years [Interquartile
range (IQR) 15–42 years] and ranged from 10 to 78 years.
Over half of the study participants were farmers below
35 years of age and with a lower level of education. Gender comparisons found more males reporting substance
use. See Table 1.
Distribution of socio-demographic characteristics, alcohol
and tobacco use by khat chewing

The prevalence of life time use of khat was 44.6% (371
out of 831) while that of current use was 36.8% (306 out
of 831). There was a significant gender difference in khat
use with 54.8% of males and 20.4% of the females reporting
khat use (p < 0.001). The rates of khat chewing in children
aged between 10 and 17 years was 13.6%. Khat chewing
was significantly associated with male sex (p < 0.001), younger age (less than 35 yrs) (p < 0001), higher level of income
(p < 0.001) and comorbid alcohol (p = 0.001) and tobacco
use (p < 0.001). No significant association was seen with
level of education and occupation. See Table 2.
Pattern of khat chewing according to gender

Forty-four percent of the participants had attained the
age of 15 years when they first started chewing khat,
however of note is that more females (32.6%) reported
starting to chew khat under 10 years of age compared to
males (12.6%). Nearly half of the khat users reported
daily use of khat and chewing between one to three
bunches of khat in a sitting. Many (76.7%) had chewed
khat over a 10 year duration. There was a statistically
significant difference in the distribution pattern of khat
use between males and females based on age at first use
(p < 0.001), frequency (p = 0.016), amount (p = 0.001)
and duration of khat chewing (p < 0.001). See Table 3.
Distribution of socio-demographic characteristics by
psychotic symptoms

The overall rate of at least one psychotic symptom in
the study population was 16.7%. Females had a significantly higher rate of reporting compared to males (p =
0.023). The age group of young adults reported significantly higher rates (p < 0.001) with paranoid symptoms
featuring predominantly (15.7%). See Table 4.
Distribution of substance use by psychotic symptoms

Both hallucinations and strange experiences were significantly associated with khat chewing P value 0.0017
and 0.024 respectively. Khat users had higher rates of
all symptoms (although not significant) except mania/

Khat chewing
n

%Chew

Male

396

54.8

Female

435

20.5

P-value

Sex
< 0.001

Age group in years
10–17

280

13.6

18–35

235

50.6

36–50

196

46.9

> 50

118

48.3

Up to primary

465

49.2

Secondary

67

50.7

Tertiary

17

23.5

Formal & Self employed

74

60.8

Farmer

429

46.4

Casual, domestic & other

37

51.4

< 5000

161

41.0

5000- < 50000

275

55.6

50000 & over

24

79.2

Yes

111

78.4

No

718

30.5

Yes

31

64.5

No

798

35.8

< 0.001

Education (Adults only)
0.107

Occupation (Adults only)
0.068

Income (Adults only)
< 0.001

Tobacco use (Daily or almost daily)
< 0.001

Alcohol use (Daily or almost daily)
0.001

hypomania, which is a mood component. Excluding
mania/hypomania symptoms, khat users still had
higher rates of overall psychosis at 16.7% compared
to 12.8% for non-users with no significant difference
(p = 0.12). Daily use of tobacco was significantly associated with thought control, paranoid and hallucination symptoms of psychosis while daily use of
alcohol was significantly associated with almost all
symptoms of psychosis except manic/hypomanic
symptoms. See Table 5. A total of 23 (2.8%) participants were taking other psychotomimetic substances
(cannabis 10; inhalants 7; sleeping pills 1; heroin/morphine/pain medicine 4; and a combination of cannabis, sleeping pills & hallucinogens 1). Statistical
evaluation of use of any of the psychotomimetic substances and psychotic-like symptoms of participants,
did not show significant associations.
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Table 3 Pattern of khat chewing by gender
Total
(N = 306)

P-value

32.6

18.3

< 0.001

32.6

37.5

47.9

34.9

44.2

One day per week

3.3

9.8

5.2

2–3 days per week

26.3

37.8

29.6

4–6 days per week

16.3

13.4

15.5

Everyday

54.1

39.0

49.8

Less than one

23.0

42.0

28.5

Between 1 and 3

49.8

47.7

49.2

Between 3 and 5

10.6

6.8

9.5

More than 5

16.6

3.4

12.8

Characteristic

Gender, %
Male (N = 217)

Female (N = 89)

Under 10 years

12.6

Between 10 and 15 years

39.5

above 15 years

Age when started khat chewing

Khat chewing pattern
0.016

Bunches chewed in a sitting
0.001

Number of years chewing khat
< than 1 year

–

–

–

1–4 years

9.3

29.1

15.0

5–10 years

7.9

9.3

8.3

> 10 years

82.8

61.6

76.7

Logistic regression analysis for strange experiences and
hallucinations in relation to Khat use

Adjusting for age, sex and tobacco use, the odds of
reporting strange experiences was elevated in Khat users
at OR, 2.45; 95%CI, 1.13–5.34. Similarly, khat use was
associated with higher odds of experiencing hallucinations (OR, 2.08; 95% C.I, 1.06–4.08) controlling for sex,
age and alcohol use. See Table 6.

Discussion
The lifetime prevalence of khat use in the study participants was 44.6%. This study found a high overall prevalence of current khat use (36.8%). This prevalence is
comparable to a study in Ethiopia reporting a 37.8%
prevalence of current khat use [35] but lower than rates in
recent population based study in Yemen (80%) [24, 36].
Khat is thought to be a cash crop in this study area, our
study findings however show that khat is not only grown
for sale but also locally consumed by the residents. Similar
to previous khat studies our study found significant gender differences with khat use predominantly being reported in males [37, 38]. Of note is that in our study
setting khat is culturally chewed primarily by men. Few
studies have reported on khat use in children, though the
rates of chewing in children in our study were only 13.6%;
low compared to studies earlier done in Yemen [36], it still

< 0.001

is a worrisome figure as earlier initiation of substance use is
linked to increased risk of drug related morbidity [39, 40].
The overall rates of at least one psychotic symptom reported were slightly higher (16.7%) compared to a local
household based study conducted in Western Kenya
(13.9%) [31]. Varying levels of risk factors particularly
exposure to substance use may explain the difference
seen. Interestingly however, unlike similar population
based khat studies elsewhere [41], we found a significantly higher rate of psychotic symptoms reported in
women compared to men; a finding that was similarly
observed in a Western Kenya population survey study
[31] . Because khat is predominantly chewed by men it
is assumed that men would present with higher levels of
psychiatric morbidity including psychosis compared to
women which is not the case here. One theory could
perhaps be a difference in vulnerability to the exposure
to khat however, this is unlikely in our study as reported
psychotic symptoms were significantly higher in women
compared to men regardless of their use of khat. Previous studies have demonstrated an increased stress sensitivity in women compared to men [42, 43]. Of note is
that greater stress sensitivity has been significantly associated with increases in positive psychotic symptoms
among females [44]. This could offer one explanation to
the higher rates of psychotic symptoms seen in women
compared to men in our study. This higher reporting of
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Table 4 Distribution of socio-demographic characteristics by psychotic symptoms
Parameter

N

Mania/ Hypomania

Thought control

Paranoia

Strange experiences

Hallucinations

Any symptom

%

%

%

%

%

%

Sex
Male

396

2.5

3.8

7.3

3.0

4.3

13.6

Female

435

3.2

4.4

11.5

5.5

7.1

19.5

0.551

0.673

0.041

0.079

0.080

0.023

P-value
Age group
10–17

280

2.5

1.8

3.2

1.4

2.5

10.4

18–35

235

5.1

7.2

15.7

6.8

9.8

26.0

36–50

196

1.5

4.1

8.2

4.6

4.6

13.8

> 50

118

1.7

3.4

14.4

5.9

7.6

18.6

0.105

0.020

< 0.001

0.019

0.003

< 0.001

P-value
Education (Adults only)
Up to primary

465

3.4

5.6

13.8

6.0

7.5

21.1

Secondary

67

1.5

4.5

9.0

6.0

7.5

16.4

Tertiary

17

P-value

0

0

0

0

5.9

5.9

nv

nv

0.151

nv

0.968

0.225

2.7

2.7

6.8

4.1

8.1

14.9

Occupation (adults only)
Formal & Self employed

74

Farmer

429

3.3

5.4

13.8

6.3

7.2

20.5

Casual, domestic & other

37

2.7

10.8

13.5

5.4

8.1

34.3

nv

nv

0.248

nv

0.951

0.423

P-value

Income (Monthly income for adults only)
< 5000

161

5.0

6.2

17.4

5.6

6.2

22.4

5000- < 50000

275

2.9

5.5

10.5

6.9

8.0

20.4

50000 & over

24

P-value

0

4.2

8.3

4.2

0

8.3

0.334

0.899

0.095

0.781

0.302

0.282

nv Chi-square not valid, * = Fisher’s Exact Probability

Table 5 Distribution of substance use by psychotic symptoms
Parameter

N

Mania/ Hypomania

Thought control

Paranoia

Strange experiences

Hallucinations

Any symptom

%

%

%

%

%

%

Khat use
Yes

306

2.6

5.6

10.5

6.5

8.2

18.6

No

525

3.0

3.2

9.0

3.0

4.4

15.6

0.719

0.104

0.476

0.017

0.024

0.262

P-value

Tobacco use (Daily or almost daily)
Yes

111

5.4

8.1

16.2

9.9

9.0

27.0

No

718

2.5

3.5

8.5

3.5

5.3

15.2

0.119

0.002

32.3

P-value

0.089

a

a

0.028

0.010

a

0.005

Alcohol use (Daily or almost daily)
Yes

31

3.2

12.9

22.6

12.9

19.4

No

798

2.9

3.8

9.0

4.0

5.3

P-value

0.605

a

a

0.034

a

0.022

a

0.041

16.2
a

0.007

0.019

nv Chi-square not valid, a = Fisher’s Exact Probability
Sex, age group, current Khat chewing, tobacco and alcohol use were subjected to binary logistic regression using backward stepwise (LR) method for strange
experiences as well as hallucinations and following tables shows the variables that were retained in the models
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Table 6 Results of Logistic regression analysis for Strange experiences and Hallucinations
Variable

Categories

β

S.E.(β)

p-value

AORa

95% CI for AOR
Lower

Upper

Strange experiences
Sex

Khat use

Tobacco use

Female

−0.752

Male

Reference

0.231

< 0.001

5.828

2.211

15.362

0.324

0.024

2.453

1.126

5.340

0.292

0.001

5.903

2.095

16.636

−4.935

0.520

< 0.001

0.007

0.368

0.005

2.787

1.356

5.728

0.462

0.024

2.840

1.148

7.023

Yes

−0.568

No

Reference

Yes

1.048

No

Reference

Constant
Hallucinations
Sex

Age group in years

Khat use

Alcohol use

Constant

Female

1.025

Male

Reference

10–17

Reference

18–35

1.044

36–50

0.367

0.531

0.489

1.444

0.510

4.089

Over 50

1.082

0.535

0.043

2.950

1.033

8.420

Yes

0.733

0.343

0.033

2.080

1.062

4.077

No

Reference
0.518

0.004

4.446

1.612

12.261

0.499

< 0.001

0.011

Yes

1.492

No

Reference
−4.470

AOR Adjusted Odds Ratio

a

psychotic symptoms among females than males is in
congruent to findings of the Western Kenya study that
examined psychotic symptoms in a general population.
Though we did not measure life events in the present
study, exposure to life events measured in the Western
Kenya study found a significant association between experiencing a life events and reporting of psychotic symptoms. When life events were analysed by sex in the
study, 4 individual life events namely serious illness, injury or assault to self, bullying, violence at home and
running away from your home were associated with increased risk of having psychotic symptoms in females,
while none of the same or other life events were associated with increased risk of having psychotic symptoms
in males. This finding further supports the theory of
gender difference in stress reactivity.
Regarding psychotic symptom profile, khat using participants were more likely to report experiencing strange
events and hallucinations compared to other psychotic
symptoms. Other studies have linked khat associated
psychosis with mania and paranoid symptoms two
symptoms that were not statistically significant in this
study [45]. It is worth mentioning that a number of
studies have continually shown a high rate of concurrent
substance use among khat users [46, 47]. Evidenced also

in this study with high rates of concurrent cigarette and
alcohol use. Polysubstance use may impact on khat related psychosis symptom profile [48, 49]. Alcohol related
psychosis for example is primarily characterized by hallucinations while stimulants more commonly induce
paranoid symptoms of psychosis [50, 51].
After combining all psychotic symptoms no significant
association was seen with psychosis for khat users. However, when looking at individual psychotic symptoms
both the unadjusted and adjusted analysis, khat use was
associated with elevated odds of reporting strange experiences and hallucinations. Based on the cross-sectional
nature of our study design it is difficult to conclude on
what came first, whether khat itself caused psychosis or
whether the participants with existing psychotic disorders used khat in an attempt to alleviate psychotic symptoms. Further, as there was no time line provided for the
psychotic experiences and khat use in the interview
questions, it is possible that khat users experienced these
psychotic symptoms only when they were under influence of khat (acute intoxication) and not in a more persistent way. In this study, we set out to look at discrete
psychotic symptoms rather than to make diagnoses of
psychotic disorders. The psychosis screening items on
the PSQ were used for this purpose since the instrument
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has been used in our setting in the past [31], and these
are the same questions that would be used to screen for
psychotic symptoms in a clinical setting, whether children
or adults. Additionally, the items are similar to those in a
validated adolescent screening [52]. The strength of this
study is the relatively large population size recruited using
random sampling techniques. However, our study was conducted in a primarily rural population in eastern Kenya and
hence generalizability to other populations is unknown.
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